Member Exclusive

Combination of immunotherapeutics shows promise in murine glioblastoma

Researchers at the Children's Hospital of Eastern Ontario (Ottawa, ON, Canada) have discovered that SMAC Mimetic compounds and immune checkpoint inhibitors work synergistically and could be utilized in clinical application against cancerous tumors.

Go to the profile of Peter Brown
Feb 27, 2017

Please sign in or register for FREE

Register to MedChemNet – the medicinal chemistry network

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.